• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2刺突蛋白和核衣壳蛋白中保守表位的鉴定

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein.

作者信息

Forcelloni Sergio, Benedetti Anna, Dilucca Maddalena, Giansanti Andrea

机构信息

Mechanisms of Protein Biogenesis, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.

Sapienza University of Rome, Department of Physics, P.le A. Moro 5, 00185 Rome, Italy.

出版信息

Curr Genomics. 2021 Dec 31;22(7):541-549. doi: 10.2174/1389202923666211216162605.

DOI:10.2174/1389202923666211216162605
PMID:35386436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8905637/
Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that first occurred in Wuhan in December 2019. The spike glycoproteins and nucleocapsid proteins are the most common targets for the development of vaccines and antiviral drugs.

OBJECTIVE

We herein analyze the rate of evolution along with the sequences of spike and nucleocapsid proteins in relation to the spatial locations of their epitopes, previously suggested to contribute to the immune response caused by SARS-CoV-2 infections.

METHODS

We compare homologous proteins of seven human coronaviruses: HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HCoV-HKU1, MERS-CoV, and SARS-CoV-2. We then focus on the local, structural order-disorder propensity of the protein regions where the SARS-CoV-2 epitopes are located.

RESULTS

We show that most of nucleocapsid protein epitopes overlap the RNA-binding and dimerization domains, and some of them are characterized by a low rate of evolutions. Similarly, spike protein epitopes are preferentially located in regions that are predicted to be ordered and well- conserved, in correspondence of the heptad repeats 1 and 2. Interestingly, both the receptor-binding motif to ACE2 and the fusion peptide of spike protein are characterized by a high rate of evolution.

CONCLUSION

Our results provide evidence for conserved epitopes that might help develop broad-spectrum SARS-CoV-2 vaccines.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种于2019年12月首次出现在武汉的新型病毒。刺突糖蛋白和核衣壳蛋白是疫苗和抗病毒药物研发中最常见的靶点。

目的

我们在此分析刺突蛋白和核衣壳蛋白序列的进化速率及其与表位空间位置的关系,此前有研究表明这些表位有助于引发由SARS-CoV-2感染引起的免疫反应。

方法

我们比较了七种人类冠状病毒的同源蛋白:HCoV-229E、HCoV-OC43、SARS-CoV、HCoV-NL63、HCoV-HKU1、MERS-CoV和SARS-CoV-2。然后我们重点关注SARS-CoV-2表位所在蛋白质区域的局部结构有序-无序倾向。

结果

我们发现,大多数核衣壳蛋白表位与RNA结合域和二聚化域重叠,其中一些表位的进化速率较低。同样,刺突蛋白表位优先位于预测为有序且保守的区域,对应于七肽重复序列1和2。有趣的是,刺突蛋白与ACE2的受体结合基序和融合肽的进化速率都很高。

结论

我们的结果为保守表位提供了证据,这些表位可能有助于开发广谱SARS-CoV-2疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/83f396b8b4d5/CG-22-541_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/4ef44b0e9e05/CG-22-541_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/c21be363f306/CG-22-541_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/69248e7ba5fe/CG-22-541_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/83f396b8b4d5/CG-22-541_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/4ef44b0e9e05/CG-22-541_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/c21be363f306/CG-22-541_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/69248e7ba5fe/CG-22-541_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb1c/8905637/83f396b8b4d5/CG-22-541_F4.jpg

相似文献

1
Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein.严重急性呼吸综合征冠状病毒2刺突蛋白和核衣壳蛋白中保守表位的鉴定
Curr Genomics. 2021 Dec 31;22(7):541-549. doi: 10.2174/1389202923666211216162605.
2
Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43.针对刺突蛋白与核衣壳蛋白相互作用的抑制和人冠状病毒 OC43 的检测。
Front Immunol. 2022 Mar 10;13:835333. doi: 10.3389/fimmu.2022.835333. eCollection 2022.
3
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics.SARS-CoV-2 及其他人类冠状病毒:通过分子系统发生学对蛋白酶识别位点、刺突蛋白抗原性变异及其分组的研究。
Infect Genet Evol. 2021 Apr;89:104729. doi: 10.1016/j.meegid.2021.104729. Epub 2021 Jan 23.
4
Properties of Coronavirus and SARS-CoV-2.冠状病毒及新型冠状病毒(SARS-CoV-2)的特性
Malays J Pathol. 2020 Apr;42(1):3-11.
5
Active site-based analysis of structural proteins for drug targets in different human Coronaviruses.基于活性位点对不同人类冠状病毒中药物靶点结构蛋白的分析。
Chem Biol Drug Des. 2022 Apr;99(4):585-602. doi: 10.1111/cbdd.14004. Epub 2022 Feb 1.
6
Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants.鉴定核衣壳(N)蛋白中的 B 细胞线性表位 主要 SARS-CoV-2 变体中保守的 B 细胞线性表位。
Viruses. 2023 Apr 6;15(4):923. doi: 10.3390/v15040923.
7
An overview on the seven pathogenic human coronaviruses.七种人类致病冠状病毒概述。
Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2.
8
[Molecular epidemiological study of human coronavirus OC43 in Shanghai from 2009-2016].2009 - 2016年上海地区人冠状病毒OC43的分子流行病学研究
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jan 6;52(1):55-61. doi: 10.3760/cma.j.issn.0253-9624.2018.01.011.
9
Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis.用于特异性分析的人冠状病毒蛋白质微阵列的开发与应用
Anal Chem. 2021 Jun 1;93(21):7690-7698. doi: 10.1021/acs.analchem.1c00614. Epub 2021 May 19.
10
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors.人类冠状病毒229E和NL63刺突蛋白内的高度保守区域决定了它们对各自细胞受体的识别。
J Virol. 2006 Sep;80(17):8639-52. doi: 10.1128/JVI.00560-06.

引用本文的文献

1
Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies.人源单克隆抗体对严重急性呼吸综合征冠状病毒2核衣壳RNA结合结构域的表位识别
iScience. 2024 Jan 19;27(2):108976. doi: 10.1016/j.isci.2024.108976. eCollection 2024 Feb 16.
2
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
3
Clinical Performance of Rapid and Point-of-Care Antigen Tests for SARS-CoV-2 Variants of Concern: A Living Systematic Review and Meta-Analysis.

本文引用的文献

1
Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.利用反向疫苗学方法鉴定具有广泛覆盖度的高度保守 SARS-CoV-2 抗原表位。
Viruses. 2021 Apr 28;13(5):787. doi: 10.3390/v13050787.
2
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients.SARS-CoV-2 全基因组 T 细胞表位图谱分析揭示了 COVID-19 患者中的免疫优势和大量 CD8+T 细胞激活。
Sci Immunol. 2021 Apr 14;6(58). doi: 10.1126/sciimmunol.abf7550.
3
An interactive website tracking COVID-19 vaccine development.
关注的 SARS-CoV-2 变异株的快速和即时抗原检测的临床性能:一项实时系统评价和荟萃分析。
Viruses. 2022 Jul 6;14(7):1479. doi: 10.3390/v14071479.
4
From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.从重组关键抗原到准确、可负担的血清学检测:从新冠疫情中汲取的经验教训,以应对未来大流行。
Biochem Eng J. 2022 Aug;186:108537. doi: 10.1016/j.bej.2022.108537. Epub 2022 Jul 16.
5
A Bioinformatics Approach to Investigate Structural and Non-Structural Proteins in Human Coronaviruses.一种用于研究人类冠状病毒结构蛋白和非结构蛋白的生物信息学方法。
Front Genet. 2022 Jun 14;13:891418. doi: 10.3389/fgene.2022.891418. eCollection 2022.
6
Integration of RT-LAMP and Microfluidic Technology for Detection of SARS-CoV-2 in Wastewater as an Advanced Point-of-Care Platform.基于 RT-LAMP 和微流控技术的废水 SARS-CoV-2 检测:一种先进的即时检测平台
Food Environ Virol. 2022 Dec;14(4):364-373. doi: 10.1007/s12560-022-09522-3. Epub 2022 May 4.
7
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.抗 SARS-CoV-2 疫苗和单克隆抗体应对病毒变异。
Viruses. 2021 Jun 18;13(6):1171. doi: 10.3390/v13061171.
8
Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation.采用大肠杆菌和 CHO 细胞表达的 SARS-CoV-2 核衣壳蛋白的双 ELISA 揭示了 N-糖基化引起的表位掩盖。
Biochem Biophys Res Commun. 2021 Jan 1;534:457-460. doi: 10.1016/j.bbrc.2020.11.060. Epub 2020 Nov 20.
9
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.从 SARS-CoV-2 患者血浆中鉴定免疫显性线性表位。
PLoS One. 2020 Sep 9;15(9):e0238089. doi: 10.1371/journal.pone.0238089. eCollection 2020.
一个追踪新冠疫苗研发情况的交互式网站。
Lancet Glob Health. 2021 May;9(5):e590-e592. doi: 10.1016/S2214-109X(21)00043-7. Epub 2021 Mar 2.
4
The immunodominant and neutralization linear epitopes for SARS-CoV-2.针对 SARS-CoV-2 的免疫显性和中和线性表位。
Cell Rep. 2021 Jan 26;34(4):108666. doi: 10.1016/j.celrep.2020.108666.
5
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.鉴定 SARS-CoV-2 核衣壳和刺突 T 细胞表位以评估 T 细胞免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02002-20.
6
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.基于 SARS-CoV-2 核衣壳蛋白的免疫信息学分析与 COVID-19 疫苗靶点的鉴定
Front Immunol. 2020 Oct 28;11:587615. doi: 10.3389/fimmu.2020.587615. eCollection 2020.
7
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.刺突蛋白和核衣壳蛋白中的线性 B 细胞表位可作为 SARS-CoV-2 暴露和疾病严重程度的标志物。
EBioMedicine. 2020 Aug;58:102911. doi: 10.1016/j.ebiom.2020.102911. Epub 2020 Jul 22.
8
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.COVID-19 患者体内诱导中和抗体的 SARS-CoV-2 刺突蛋白上的两个线性表位。
Nat Commun. 2020 Jun 1;11(1):2806. doi: 10.1038/s41467-020-16638-2.
9
Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.SARS-CoV-2 基因的密码子使用和表型差异。
Viruses. 2020 Apr 30;12(5):498. doi: 10.3390/v12050498.
10
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.SARS-CoV-2 细胞受体基因 ACE2 在多种人类组织中的表达。
Infect Dis Poverty. 2020 Apr 28;9(1):45. doi: 10.1186/s40249-020-00662-x.